Ares Capital Corporation filings document the regulatory record of a closed-ended specialty finance company with common stock listed on the Nasdaq Global Select Market. Its periodic and current reports disclose operating results, financial condition, dividend declarations, portfolio measures, leverage, and capital-structure activity tied to its investment portfolio.
The company’s Form 8-K filings include financial results releases, material definitive agreements, equity distribution agreements, funding facility amendments and note indenture disclosures. Proxy materials cover annual meeting matters, director elections and auditor ratification, while related vote-result filings record stockholder approvals and governance outcomes.
Ares Capital Corporation is asking stockholders to approve an authorization to sell or issue common stock at prices below net asset value (NAV) in specific situations. The authority would apply for 12 months and is capped at 25% of then-outstanding shares. As a business development company and regulated investment company, Ares Capital argues this flexibility could help it raise equity quickly during market volatility, support its debt-to-equity limits and pursue attractive investments or acquisitions. The proxy explains that similar authority has been approved for 17 years but used only once, in 2009, in connection with an acquisition the company describes as highly accretive. The board, including a majority of independent directors, recommends voting in favor, while highlighting the potential dilutive impact on shareholders who do not participate in any below-NAV issuance.
Ares Capital Corporation entered into a Sixth Supplemental Indenture to issue $800,000,000 aggregate principal amount of its 5.550% notes due 2030. The notes are direct unsecured obligations, pay 5.550% interest semiannually starting on January 15, 2027, and mature on January 15, 2030. They may be redeemed at the company’s option at prices set in the indenture.
Ares Capital expects to use the net proceeds to repay outstanding borrowings under its credit facilities, with the ability to reborrow for general corporate purposes, including portfolio investments. The indenture includes covenants tied to Investment Company Act leverage limits and financial reporting if the company ceases to be an Exchange Act reporting company, plus a change of control repurchase feature at 100% of principal plus accrued interest.
In connection with the issuance, Ares Capital entered into an interest rate swap with a notional amount of $800,000,000, under which it receives fixed 5.550% and pays a floating rate based on one-month SOFR plus 1.69950% through January 15, 2030.
Ares Capital Corporation reported the results of its annual stockholder meeting held on May 7, 2026. Stockholders entitled to vote included 718,022,845 shares of common stock as of the record date of March 2, 2026.
Stockholders elected three Class I directors to serve until the 2029 annual meeting. Ann Torre Bates received 227,599,186 votes for, 22,887,186 against and 5,483,619 abstentions, with 256,591,998 broker non-votes. Steven B. McKeever received 193,224,033 votes for, 58,930,014 against and 3,815,944 abstentions, with 256,591,998 broker non-votes. Michael J. Arougheti received 234,472,961 votes for, 18,006,707 against and 3,490,323 abstentions, with 256,591,998 broker non-votes.
Stockholders also approved the ratification of KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2026, with 490,881,757 votes for, 16,126,434 against and 5,553,798 abstentions.
Ares Capital Corporation is offering $800,000,000 aggregate principal amount of 5.550% Notes due January 15, 2030. The Notes are being offered at 99.291% of principal and will pay interest semiannually on January 15 and July 15, beginning January 15, 2027. Net proceeds are expected to be approximately $787.9 million, which the company expects to use to repay borrowings under its revolving credit and funding facilities. The Notes are direct senior unsecured obligations, will rank pari passu with existing unsecured indebtedness, be issued in book-entry form through DTC, and will not be listed on an exchange. The Notes may be redeemed prior to the par call date and are subject to a Change of Control repurchase right at 100% of principal plus accrued interest.
Ares Capital Corporation is offering senior unsecured notes under a preliminary prospectus supplement that supplements its May 1, 2024 prospectus. The supplement describes the notes’ basic terms including semiannual interest payments, optional redemptions, and a holder repurchase right upon a Change of Control Repurchase Event.
The document states the notes will rank pari passu with other unsecured unsubordinated indebtedness, are unsecured and structurally subordinated to subsidiary indebtedness, and that net proceeds are expected to be used, in whole or in part, to repay borrowings under identified revolving and funding facilities.
The board of Ares Capital Corporation is asking common stockholders to authorize the Company to, with board approval, sell or otherwise issue up to 25% of then outstanding common stock at prices below the then-current net asset value per share. The authorization, if approved, would be effective for a twelve-month period from the Special Meeting date. The Special Meeting will be held virtually on August 13, 2026; the record date is May 12, 2026. The proposal is described as a precautionary flexibility measure for use during periods of market disruption, subject to board determinations and conditions mandated by the Investment Company Act.
Ares Capital Corporation (ARCC) filed a prospectus supplement for an at-the-market equity offering under separate equity distribution agreements to sell up to $1,500,000,000 of common stock through designated sales agents. The offering permits sales from time to time on Nasdaq and other trading venues under commercially reasonable terms, with sales-agent compensation up to 1.50% of gross proceeds. The prospectus states the company may use net proceeds to repay outstanding indebtedness and for general corporate purposes, and that sales prices will not be less than the then-current net asset value per share except with board or stockholder approval.
The supplement provides context on ARCC’s business as a closed-end BDC, portfolio focus, key financing facilities, shares outstanding of 718,022,845 as of April 23, 2026, a net asset value per share of $19.59 as of March 31, 2026, and an April 27, 2026 close price of $18.61.
Ares Capital Corporation entered new equity distribution agreements that allow it to issue and sell shares of its common stock with an aggregate offering price of up to $1,500,000,000 through multiple sales agents. These shares may be sold in negotiated deals or “at the market” transactions on the NASDAQ Global Select Market or through market makers at prices tied to prevailing or negotiated levels.
The sales agents, including Truist, Mizuho, RBC, Regions and SMBC, may earn commissions of up to 1.5% of the gross sales price of any shares sold. The company is not obligated to sell any shares and can suspend offerings at any time. On the same date, Ares Capital terminated prior equity distribution agreements from February 5, 2025 that have been superseded by these new arrangements.
Ares Capital Corporation reported first quarter 2026 results and declared a second quarter 2026 dividend of $0.48 per share, payable June 30, 2026 to stockholders of record on June 15, 2026.
For the quarter ended March 31, 2026, GAAP net income was $92 million, or $0.13 per share, compared with $241 million, or $0.36 per share, a year earlier, mainly reflecting higher net unrealized losses of $412 million. Net investment income increased to $398 million, or $0.55 per share, from $365 million, or $0.54 per share, while Core EPS was $0.47 versus $0.50.
Portfolio investments at fair value were $29.5 billion as of March 31, 2026, and net asset value per share was $19.59, slightly below $19.94 as of December 31, 2025. The debt/equity ratio was 1.13x, and loans on non-accrual status remained low at 2.1% of total investments at amortized cost and 1.2% at fair value.
Ares Capital highlighted approximately $6.0 billion of available liquidity, including $505 million of cash and $5.5 billion of capacity under credit facilities. During the quarter it issued $750 million of unsecured notes due 2031 at 5.250%, repaid $1,150 million of maturing 3.875% notes, and expanded its SMBC revolving funding facility from $1.1 billion to $1.6 billion while modestly reducing spreads.